Acute cardiorenal (type 1) Acute worsening of heart function (AHF-ACS) leading to kidney injury and/or dysfunction Acute decompensated heart failure, acute coronary syndrome Chronic cardiorenal ...

This represents the fourth indication granted a Breakthrough Device Designation for the SCD by FDA DENVER, Nov. 06, 2024 ...

Increased understanding of the cardiorenal syndrome is making the complex interactions between these organs more clear. Traditional biomarkers such as blood urea nitrogen and creatinine are not ...

TCT 72: Intravascular Imagining-Guided Percutaneous Coronary Intervention vs. Coronary Artery Bypass Grafting for Treating Unprotected Left Main Stenosis: The Multicenter ROCK III Study Receive the ...

Fannin Innovation’s Managing Partner discusses strategies, challenges in biotech investment, and what sets Fannin’s model ...

SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, reports ...

up to 261,895 new shares can be issued upon the exercise of 90,780 share options that are still outstanding under the 'Executive Share Options' plan for staff members and consultants of the Company, ...

Results of the Company's RED DESERT and SAHARA proof-of-concept studies in heart failure support DSR's mechanism of action as breaking the vicious cycle of cardiorenal syndrome. All three patients ...

New study reports protective effect among people with type 2 diabetes Kidney stones and the systemic conditions associated with them have a major impact on health and the economy in the US and ...

This connection between kidney disease and heart disease is sometimes called the “cardio-renal syndrome,” which highlights the close relationship between the heart and kidneys. In this review ...